Rosemont Pharmaceuticals
Rupert Sargeant currently serves as the International Sales & Out-Licensing Manager Rx at Rosemont Pharmaceuticals since September 2020. Prior experience includes roles as National Sales Manager Rx at Perrigo Company plc from December 2018 to September 2020, Sales Director at Rayner from September 2016 to August 2018, and Sales Director at Moorfields Pharmaceuticals from February 2012 to September 2016. Rupert Sargeant also held the position of National Sales Manager at Alcon from July 2006 to January 2012 and served as Sales Manager at Wockhardt Ltd. from July 2001 to January 2004. Earlier in the career path, Rupert Sargeant was a Key Account Manager and Sales Representative at Johnson & Johnson from February 1994 to July 2001. Rupert Sargeant completed education at Monkton Combe School from 1981 to 1986.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.